The DOI matches its Crossref record.
A Comparison of Three Doses of a Commercially Prepared Oral Midazolam Syrup in Children
Abstract
UNLABELLED: Midazolam is widely used as a preanesthetic medication for children. Prior studies have used extemporaneous formulations to disguise the bitter taste of IV midazolam and to improve patient acceptance, but with unknown bioavailability. In this prospective, randomized, double-blinded study we examined the efficacy, safety, and taste acceptability of three doses (0.25, 0.5, and 1.0 mg/kg, up to a maximum of 20 mg) of commercially prepared Versed((R)) syrup (midazolam HCl) in children stratified by age (6 mo to <2 yr, 2 to <6 yr, and 6 to <16 yr). All children were ASA class I-III scheduled for elective surgery. Subjects were continuously observed and monitored with pulse oximetry. Ninety-five percent of patients accepted the syrup, and 97% demonstrated satisfactory sedation before induction. There was an apparent relationship between dose and onset of sedation and anxiolysis (P < 0.01). Eight-eight percent had satisfactory anxiety ratings at the time of attempted separation from parents, and 86% had satisfactory anxiety ratings at face mask application. The youngest age group recovered earlier than the two older age groups (P < 0.001). There was no relationship between midazolam dose and duration of postanesthesia care unit stay. Before induction, there were no episodes of desaturation, but there were two episodes of nausea and three episodes of emesis. At the time of induction, during anesthesia, and in the postanesthesia care unit, there were several adverse respiratory events. Oral midazolam syrup is effective for producing sedation and anxiolysis at a dose of 0.25 mg/kg, with minimal effects on respiration and oxygen saturation even when administered at doses as large as 1.0 mg/kg (maximum, 20 mg) as the sole sedating medication to healthy children in a supervised clinical setting. IMPLICATIONS: Commercially prepared oral midazolam syrup is effective in producing sedation and anxiolysis in doses as small as 0.25 mg/kg; there is a slightly faster onset with increasing the dose to 1.0 mg/kg. At all doses, 97% of patients demonstrated satisfactory sedation, whereas 86% demonstrated satisfactory anxiolysis when the face mask was applied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chow, L. C., Wright, K. W., Sola, A., & the CSMC Oxygen Administration Study Group (2003) · Pediatrics · doi:10.1542/peds.111.2.339 · Cited by 491
Update on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
Drugs for preventing postoperative nausea and vomiting
Carlisle, J., & Stevenson, C. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004125.pub2 · Cited by 264
RetractedWright, K. D., Stewart, S. H., Finley, G. A., & Buffett-Jerrott, S. E. (2007) · Behavior Modification · doi:10.1177/0145445506295055 · Cited by 190
Metadata
- Authors
- Coté, C. J., Cohen, I. T., Suresh, S., Rabb, M., Rose, J. B., Weldon, B. C., Davis, P. J., Bikhazi, G. B., Karl, H. W., Hummer, K. A., Hannallah, R. S., Khoo, K. C., & Collins, P.
- Venue
- Anesthesia & Analgesia
- Published
- 2002-01
- Volume
- 94
- Issue
- 1
- Pages
- 37-43
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W1979746272
- Cited by
- 188
- References
- 0
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Comparison of Three Doses of a Commercially Prepared Oral Midazolam Syrup in Children. https://app.cochat.ai/papers/10.1097/00000539-200201000-00007
- The paper
- Coté, C. J., Cohen, I. T., Suresh, S., Rabb, M., Rose, J. B., Weldon, B. C., Davis, P. J., Bikhazi, G. B., Karl, H. W., Hummer, K. A., Hannallah, R. S., Khoo, K. C., & Collins, P. (2002). A Comparison of Three Doses of a Commercially Prepared Oral Midazolam Syrup in Children. Anesthesia & Analgesia. https://doi.org/10.1097/00000539-200201000-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.